Successful informative session on U.S. Non-dilutive funding at IDIBELL

30 Oct

Successful informative session on U.S. Non-dilutive funding at IDIBELL

NIH infoday

Este proyecto ha sido financiado con fondos del Ministerio de Ciencia, Innovación y Universidades bajo la convocatoria Redes y Gestores de la Agencia Estatal de Investigación, dentro del Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (Importe de la ayuda: 176.324 €. Ref. ECT 2017 – 0322).

   /   
<   Back to News

The “U.S. Federal sources for health Projects” informative session was successfully held at IDIBELL last October 21st. Jointly co-organized with AGAUR, the Agency for Management of University and Research Grants, the session featured two seminars on U.S. funding sources for Health Projects, that were delivered by Dr. Ana Turchetti-Maia, Director of Business Development at Freemind Consultants. 

 

Descubren la implicación de una nueva proteína en el cáncer de hígado

28 Oct

Descubren la implicación de una nueva proteína en el cáncer de hígado

   /   
<   Back to News

Investigadores del Instituto de Investigación Biomédica de Bellvitge (IDIBELL) acaban de describir por primera vez la implicación crucial de una proteína de la membrana celular en el desarrollo y progresión del cáncer de hígado, según un artículo publicado en la revista Journal of Hepatology. Esta proteína, llamada clatrina, es conocida por su papel clave en el proceso de internalización de moléculas del espacio extracelular hacia el interior de la célula, llamado endocitosis.

Scientists discover the implication of a new protein involved in liver cancer

28 Oct

Scientists discover the implication of a new protein involved in liver cancer

   /   
<   Back to News

Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have just described for the first time the crucial involvement of a cell membrane protein in the development and progression of liver cancer, according to an article published in the Journal of Hepatology. This protein, called clathrin, is known for its key role in the process of internalization of molecules from the extracellular space into the cell, called endocytosis. In this process, the cell membrane folds creating vesicles with a cladded structure.

Descobreixen la implicació d’una nova proteïna en el càncer de fetge

28 Oct

Descobreixen la implicació d’una nova proteïna en el càncer de fetge

   /   
<   Back to News

Investigadors de l'Institut d’Investigació Biomèdica de Bellvitge (IDIBELL) acaben de descriure per primera vegada la implicació crucial d'una proteïna de la membrana cel·lular en el desenvolupament i la progressió del càncer de fetge segons un article publicat a la revista Journal of Hepatology. Aquesta proteïna, anomenada clatrina, és coneguda pel seu paper clau en el procés d'internalització de molècules de l'espai extracel·lular cap a l'interior de la cèl·lula, anomenat endocitosi.

FELLOWS' SEMINAR

The Fellows' seminar series is open to all members of the IDIBELL community where PhD students and postdocs present their research in progress. The Fellows' seminars provide a forum for IDIBELL early-career researchers to discuss the results of their research with each other as well as with more experienced researchers.

 

 

Use of Orthoxenograft and Tumoroid Models to Unravel the Resistance Mechanisms in Unstable Colorectal Cancer

 

FELLOWS' SEMINAR

The Fellows' seminar series is open to all members of the IDIBELL community where PhD students and postdocs present their research in progress. The Fellows' seminars provide a forum for IDIBELL early-career researchers to discuss the results of their research with each other as well as with more experienced researchers.

 

 

Use of Orthoxenograft and Tumoroid Models to Unravel the Resistance Mechanisms in Unstable Colorectal Cancer

 

FELLOWS' SEMINAR

The Fellows' seminar series is open to all members of the IDIBELL community where PhD students and postdocs present their research in progress. The Fellows' seminars provide a forum for IDIBELL early-career researchers to discuss the results of their research with each other as well as with more experienced researchers.

 

 

Use of Orthoxenograft and Tumoroid Models to Unravel the Resistance Mechanisms in Unstable Colorectal Cancer

 

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells

24 Oct

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells

C. elegans

   /   
<   Back to News

At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely used in biomedical research by hundreds of laboratories around the world, has approximately the same number of genes that humans have, about 20,000. In addition, most human disease-causing genes have their counterparts, or orthologs, in C. elegans worms.